Inside the Credentialing Committee
What actually happens in the room that decides who gets to practice.
Twenty-six pages of paper, bound with a binder clip — that was my first privilege application, near the end of residency. Each page had blanks, dozens of them, and some asked about things I had never had reason to think about before: malpractice history. Prior privilege restrictions. Conditions that might affect my ability to practice. I filled in what I could, submitted the packet, and waited for a letter. What I understood about the room where the decision would be made was essentially nothing.
The packet runs longer now — mostly electronic, which makes it more navigable but no less foreign on first encounter. What has not changed is the opacity: you submit, you wait, a letter arrives.
Most clinicians who pass through the process do so from the applicant side only — and a long, serious clinical career can be built entirely from that vantage point. I have sat on both sides of that table. This piece is about what the second side looks like.
Fifteen years after that first application, I sat in the room where those packets are reviewed, vetted, and occasionally debated in ways the applicant will never learn about. What the applicant side had not prepared me for — and what it never quite prepares the clinician who eventually crosses that table — is how often the tension in the room is not about qualifications. Every month there is at least one scenario where a facility’s coverage need, a new service line, or a rushed application sits directly across the table from a file that is not clean. The space between what the institution needs and what is in that file can draw tight enough that a slow exhale from somewhere at the table reverberates like a plucked string.
There is a distinction that every credentialing packet papers over, and that most clinicians never encounter until they are in the room making the decision rather than waiting for it. Credentials and privileges are not the same thing.
Credentials confirm what you are. Board-certified. Licensed. Trained. The background verification that establishes you as a qualified practitioner in your field.
Privileges grant what you may do at a facility. Specific procedures. Specific patient populations. Specific settings within this institution. The authority to perform a right hepatectomy, place an arterial line, or admit patients is not conferred by your certificate. It is conferred by this committee, at this institution, in this meeting.
The committee can credential you and decline your privilege request. It can grant privileges for some procedures and withhold them for others — not because you are unqualified by training, but because the institution does not need you doing them, because the service line structure does not accommodate them, or because the complications they generate exceed what the institution can currently support. The privilege, unlike the credential, is the institution’s act. It can be withheld, restricted, or revoked for reasons your residency or training program never taught you to anticipate.
Clinicians applying for privileges typically arrive assuming the committee is reviewing their training. What the committee is actually reviewing is considerably more complicated. That review looks backward — case logs, incident history, a prior institution’s adverse action record — and forward: coverage needs, service line strategy, an institutional plan the applicant has never seen and was not required to consult.
The formal mandate of the credentialing committee is the verification of qualifications and assurance of clinical competence: the mechanism through which the institution protects the patients it serves. Every piece of documentation, every attestation, every primary source verification requirement that flows from TJC Medical Staff standards is oriented toward a single claim: the institution will only grant clinical authority to practitioners whose qualifications have been verified and whose competence is reasonably assured. This is a protection for the community served, and one that by design is managed by the medical staff itself.
That mandate is real. The National Practitioner Data Bank query, mandatory for every initial credentialing and every two-year recredentialing cycle, surfaces adverse actions, malpractice payments, and privilege restrictions at prior institutions. References are contacted in most institutions, and they often matter more than they appear to: a hedge from a reference of the applicant’s choosing is reason to look harder; an outright negative from that same reference is a major red flag. Peer review records from within the institution, where they exist, are available to the committee. Records from prior institutions are rarely available in practice. Protection statutes prevent compelled disclosure, and voluntary disclosure is inconsistent. The focused professional practice evaluation period (FPPE) that follows most initial privilege grants is a structured mechanism to verify that the granted authority is being exercised as expected.
When the process works as designed, it is an imperfect but genuine instrument for patient protection.
What the formal mandate does not capture is everything else the committee manages simultaneously.
The institution needs overnight call coverage in the cardiac procedural lab. A structural heart program has been in development for eighteen months, and the committee is reviewing a privilege request from the interventional cardiologist expected to anchor it. The service line economics behind that program are not before the committee. The coverage gap it fills is not on the agenda. The relationship between that privilege grant and the institution’s three-year strategic plan is not part of the formal record.
None of that is improper. Institutions have clinical needs. Privilege decisions that serve both quality and coverage objectives are not compromised decisions — they are how the process is supposed to work when it works. The problem is not that coverage needs influence privilege decisions. The problem is that clinicians who encounter this process as applicants have no window into it, and clinicians who cross to the other side of the table for the first time are often surprised by how much organizational intelligence the room contains that the formal mandate never names.
In the rooms I have sat in, the political overlay is visible before the quality discussion begins, even when it goes unnamed.
Some of it is overt. Two competing cardiology practices on the same medical staff is not unusual, and when an application comes before the committee from a cardiologist who would practice in that same market, the political pressure rarely arrives as stated opposition. It arrives as calibrated scrutiny: volume thresholds that no one examined closely for the previous three applications, FPPE parameters that run longer than the standard, pointed questions about outcomes at the prior institution. Committee members with referral relationships to the established groups may not even recognize the degree to which those relationships are shaping their reading of the file. A well-run committee can name this dynamic when it sees it, precisely because it is tied to a recognizable interest and operates in visible enough territory to be interrogated. The distinguishing question is whether the threshold being applied was already in place, or materialized with this application.
The more consequential version involves existing privileges rather than new applications. A neurosurgeon or orthopedic surgeon is on active staff with an unrestricted privilege set — which means, in many institutions, that the privilege form carries no age limit. When a pediatric patient comes through the emergency department with a problem that falls within that specialty, the clinician can be called. Many have not provided meaningful pediatric care since residency or fellowship.
The request that comes before the committee is not for expanded privileges. It is for restriction. The surgeon wants explicit age limits placed on the privilege form — not to gain anything, but because the next call is coming and they do not want to be in that position. The initial reaction around the table is often sympathetic. The argument is reasonable on its face: a clinician who is not current in pediatric care should not be providing pediatric care.
Then someone asks the question that changes the room: what happens when a pediatric patient presents with something that cannot wait — an intracranial hemorrhage or a vascular injury — and the privilege set the committee just amended specifically excludes children? A restriction that protects the clinician from an uncomfortable position creates a care gap that, in a community hospital without a pediatric subspecialty service, could cost a life. That is not hyperbole. I have watched an adult neurosurgeon take a toddler to the operating room within minutes of arrival to the ED for a hematoma evacuation that could not wait for transfer, because a fall from a shopping cart had produced a hemorrhage that was going to kill that child without immediate intervention.
Both paths available to the committee are uncomfortable. Neither is wrong. The committee’s job is to make the choice it can defend against both the clinician’s reasonable concern and the patient’s unanticipated need.
In many committee cultures, the department chair whose support for an application signals acceptability to the rest of the committee carries weight that the written references do not. The committee member who trained at the same institution as the applicant may read the malpractice history differently than the member who did not. The service line leader who has been waiting three years for this privilege grant will move through the FPPE requirements differently than the one whose existing coverage relationships are threatened by the new applicant.
These dynamics do not make the process corrupt. They highlight its humanity. People read the same application through the lens of their own institutional position, their own professional relationships, and their own reading of what the organization needs. The committee’s job is to produce a quality-grounded decision in the presence of those dynamics, not in their absence.
The medical staff leader who understands this is not more cynical about the process. That physician is more useful to it — more able to see when a quality concern is genuine and when it is a quality-framed version of a different concern, and to recognize which situation requires a harder conversation than the room is currently having. In the pediatric coverage example, the harder conversation is not approval or denial. It is whether the privilege can be structured — through a defined scope, or a clear escalation pathway — in a way that acknowledges the gap honestly and builds the protection into the approval itself.
Peer review protection is what most physician executives encounter first and understand last.
When the committee gets a difficult decision wrong — when political pressure overrides a genuine quality concern, or when a legitimate quality concern is being borrowed to cover something else — there is very little external check. The protection that ensures it stays that way is not incidental to the process. It is built into it.
The protection exists for legitimate reasons. Candid clinical review requires confidentiality. If the committee’s deliberations about a privilege concern were fully discoverable, the risk management calculus would suppress exactly the honest discussion the protection is designed to enable. In most states, the deliberations of a credentialing committee, and the documents produced in peer review proceedings that come to the committee for review, are shielded from discovery in civil litigation for precisely this reason. The process producing the most consequential decisions about a clinician’s right to practice is also, by design, one of the least externally transparent processes in institutional governance. When the committee gets it right, that confidentiality serves everyone. When it gets it wrong, the primary accountability is internal. External mechanisms — Joint Commission reviews, state medical board proceedings, and mandatory federal adverse action reporting — can reach the same questions from a different angle, but they operate at a distance and rarely intervene in the committee’s deliberative process itself.
The physician executive who recognizes this asymmetry is better positioned to ask the harder question — not “is this decision defensible?” but “is the quality concern doing the work, or is it being borrowed for a different purpose?”
For the clinician still on the applicant side of this process — which, for many, is the only side they will occupy — the preceding sections are useful context. For the one moving toward the governance seat, they are the starting frame.
What this means for the physician executive is specific. The culture of the committee is largely the committee’s own responsibility to build and maintain, and within the committee, that responsibility sits most heavily with the senior clinical executive in the governance structure: the CMO, Chief of Staff, or VP Medical Affairs, depending on how the institution has organized that authority. That executive is the clinical voice that shapes what questions get asked, how the room holds the discomfort of a file that is not clean, and whether quality remains the actual driver when a difficult decision is on the table. The physician executive who is not in that seat needs to understand what that culture has already built before they can contribute to it — or challenge it. The question of whether quality is the actual driver of a privilege restriction, or whether something else is operating under that label, can only be asked honestly inside the room. It requires institutional credibility and interpersonal directness. And it requires a clear answer to whose interest the process is meant to serve.
The answer is the patient.
The obligations described here belong to the medical staff leader specifically, because the committee room is, structurally, a physician’s room.
What the physician executive owes the credentialing process is not complexity for its own sake. It is two things, held together, that are in tension often enough to deserve naming.
The first is genuine quality protection. When the NPDB query surfaces something significant, the committee’s job is to take it seriously — not to find a path through it because the coverage need is real or the department chair is enthusiastic. When a colleague’s FPPE reveals a pattern, the committee’s job is to address it before extending the privilege, not after. The threshold is patient safety. Everything else is secondary to it.
The second is organizational honesty about the other things the committee is managing. Coverage needs, service line strategy, departmental relationships — these are legitimate institutional concerns that properly shape how privileges are structured and what proctoring arrangements accompany them. The mistake is not that these concerns exist. The mistake is pretending they are not in the room when everyone present can see that they are, or worse, clothing them in quality language they have not earned.
The physician executive who can hold both of those responsibilities simultaneously is doing something that neither a credentialing committee operating as a purely administrative function nor a medical staff organized purely around clinical autonomy can do on its own. That physician executive is translating between the institution’s organizational reality and its quality obligation, in the specific room where those two things have to coexist. The same logic that produced a structured privilege scope in the pediatric example applies to every table conversation where the quality and the organizational concerns are both real.
The clinician who goes through credentialing as an applicant learns that the process has rules. The physician leader who sits on the committee learns that the process has a culture, and that the culture — not the rules — is what determines whether the process actually does what it claims to do.
Building that culture is not a credentials task. It is not a compliance task. It is the exercise of the specific authority the physician executive carries into a room where the institution is making decisions about clinical practice — decisions that reach forward into every patient encounter involving every clinician the committee approves.
That is the work the training did not name. Being clear-eyed about what it requires is where it starts.
Somewhere, right now, a clinician is filling in those blanks and waiting for a letter. What they know about the room where the decision will be made is essentially nothing.
Past the Door publishes free pieces every Sunday and paid pieces every other Friday. If this one was useful, forwarding it to a colleague navigating the executive transition is the best endorsement.